CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 57 filers reported holding CIDARA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $133,000 | -85.9% | 50,075 | -89.4% | 0.00% | -85.7% |
| Q4 2020 | $944,000 | -41.1% | 471,839 | -16.1% | 0.02% | -61.1% |
| Q3 2020 | $1,604,000 | -22.1% | 562,713 | +0.8% | 0.05% | -27.0% |
| Q2 2020 | $2,060,000 | +44.4% | 558,215 | -3.0% | 0.07% | -3.9% |
| Q1 2020 | $1,427,000 | -20.9% | 575,292 | +22.4% | 0.08% | -7.2% |
| Q4 2019 | $1,805,000 | +94.9% | 470,120 | +1.3% | 0.08% | +62.7% |
| Q3 2019 | $926,000 | +26.0% | 464,164 | +6.1% | 0.05% | +41.7% |
| Q2 2019 | $735,000 | -37.1% | 437,315 | -0.8% | 0.04% | -42.9% |
| Q1 2019 | $1,169,000 | +5.4% | 441,047 | -6.5% | 0.06% | -20.3% |
| Q4 2018 | $1,109,000 | -47.5% | 471,725 | -1.8% | 0.08% | -31.3% |
| Q3 2018 | $2,113,000 | -10.9% | 480,131 | +5.3% | 0.12% | -19.6% |
| Q2 2018 | $2,371,000 | – | 455,994 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,508,794 | $6,639,000 | 3.14% |
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $5,970,000 | 2.92% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 437,357 | $1,924,000 | 2.88% |
| Stonepine Capital Management, LLC | 656,148 | $2,887,000 | 1.69% |
| Opaleye Management Inc. | 1,200,000 | $5,280,000 | 1.34% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $5,774,000 | 1.06% |
| Aisling Capital LLC | 1,021,148 | $4,493,000 | 0.97% |
| Prosight Management, LP | 324,902 | $1,430,000 | 0.80% |
| BVF INC/IL | 1,930,670 | $8,495,000 | 0.75% |
| Monashee Investment Management LLC | 480,851 | $2,116,000 | 0.45% |